UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series

Frontiers in oncology, 2022-04, Vol.12, p.855782-855782

2022

Volltextzugriff (PDF)

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Clinical cancer research, 2018-11, Vol.24 (21), p.5250-5260

2018

Volltextzugriff (PDF)

Sarcoidosis, malignancy and immune checkpoint blockade

Immunotherapy, 2017-10, Vol.9 (13), p.1051-1053

Gaughan, Elizabeth M

2017

Volltextzugriff (PDF)

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

Journal for immunotherapy of cancer, 2016-12, Vol.4 (1), p.94-94, Article 94

2016

Volltextzugriff (PDF)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients

Journal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.163-13, Article 163

2019

Volltextzugriff (PDF)

Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary Practice

Annals of surgery, 2023-06, Vol.277 (6), p.e1306-e1312

2023

Volltextzugriff (PDF)

Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities

Therapeutic Advances in Medical Oncology, 2011-05, Vol.3 (3), p.113-125

2011

Volltextzugriff (PDF)

PD-L1 and MHC Class I Expression in High-grade Ovarian Cancers, Including Platinum-resistant Recurrences Treated With Checkpoint Inhibitor Therapy

Applied immunohistochemistry & molecular morphology, 2023-04, Vol.31 (4), p.197

2023

Volltextzugriff (PDF)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma

Frontiers in oncology, 2023-08, Vol.13

2023

Volltextzugriff (PDF)

Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases

Cancers, 2023-06, Vol.15 (12), p.3255

2023

Volltextzugriff (PDF)

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1898105-1898105

2021

Volltextzugriff (PDF)

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005424

2022

Volltextzugriff (PDF)

Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series

Cardio-oncology (London, England), 2020-09, Vol.6 (1), p.21-21, Article 21

2020

Volltextzugriff (PDF)

Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations

Lung cancer (Amsterdam, Netherlands), 2013-03, Vol.79 (3), p.193-197

2013

Volltextzugriff (PDF)

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e003220

2021

Volltextzugriff (PDF)

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e000934

2021

Volltextzugriff (PDF)

Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanoma

American journal of ophthalmology case reports, 2022-03, Vol.25, p.101351, Article 101351

2022

Volltextzugriff (PDF)

Comparing the rate of immunotherapy treatment change due to toxicity by sex

Cancer reports, 2024-02, Vol.7 (2), p.e1932-n/a

2024

Volltextzugriff (PDF)

HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management

BMC urology, 2009-08, Vol.9 (1), p.10-10, Article 10

2009

Volltextzugriff (PDF)

Adjuvant polypeptide vaccines for high-risk uveal melanoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21509-e21509

2023

Volltextzugriff (PDF)

Second Primary Ipsilateral Breast Cancer With Contralateral Axillary Involvement: A Case Report and Literature Review

Clinical breast cancer, 2011-12, Vol.11 (6), p.406-408

2011

Volltextzugriff (PDF)

Operationalizing Vulnerability: Land System Dynamics in a Transfrontier Conservation Area

Land (Basel), 2019-07, Vol.8 (7), p.111

2019

Volltextzugriff (PDF)

Bilateral Mydriasis and Serous Retinal Detachments Associated With Ipilimumab and 6-Melanoma Helper Peptide Vaccine for Cutaneous Melanoma

JAMA ophthalmology, 2019-09, Vol.137 (9), p.1088

2019

Volltextzugriff (PDF)

Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy

Journal of the American College of Surgeons, 2021-11, Vol.233 (5), p.S246

2021

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(88)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Sarcoidosis, malignancy and immune checkpoint blockade

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients

Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary Practice

Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities

PD-L1 and MHC Class I Expression in High-grade Ovarian Cancers, Including Platinum-resistant Recurrences Treated With Checkpoint Inhibitor Therapy

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma

Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series

Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanoma

Comparing the rate of immunotherapy treatment change due to toxicity by sex

HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management

Adjuvant polypeptide vaccines for high-risk uveal melanoma

Second Primary Ipsilateral Breast Cancer With Contralateral Axillary Involvement: A Case Report and Literature Review

Operationalizing Vulnerability: Land System Dynamics in a Transfrontier Conservation Area

Bilateral Mydriasis and Serous Retinal Detachments Associated With Ipilimumab and 6-Melanoma Helper Peptide Vaccine for Cutaneous Melanoma

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy

Suchergebnisse filtern